Literature DB >> 25458791

Novel role of Sarco/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analog.

Lu Fan1, Ang Li1, Wanshuai Li1, Peifen Cai2, Baofang Yang1, Minxia Zhang1, Yanhong Gu2, Yongqian Shu2, Yang Sun1, Yan Shen1, Xuefeng Wu1, Gang Hu3, Xudong Wu4, Qiang Xu5.   

Abstract

Sarco/endoplasmic reticulum calcium ATPase (SERCA) enzymes play important roles in several signal transduction pathways that control proliferation, differentiation and apoptosis. Here, we reported that SERCA2 expression was positively correlated with tumor node metastasis (TNM) stages (n=75, P=0.0251) and grades (n=63, P=0.0146) of patients with colorectal cancer. The animal experiments demonstrated that SERCA2 expression was consistent with PCNA staining of intestinal tissues of male C57BL/6J-Apc(Min/)JNju mice. Besides, SERCA2 expression was also increased in undifferentiated HT-29 cells as compared with that in differentiated HT-29gal cells. Moreover, SERCA2 overexpression promoted proliferation and migration of SW480 cells via activating MAPK and AKT signaling pathways, while silence of SERCA2 inhibited the proliferation and migration of SW480 cells. In addition, we identified that a curcumin analog, F36, exhibited more potent inhibitory effect in colorectal cancer cells than curcumin through inhibiting SERCA2 expression. Taken together, our findings indicate that SERCA2 is involved in the malignant progress of colorectal cancer and maybe a therapeutic target for colorectal cancer treatment. Curcumin analog F36 shows enhanced anti-cancer activity in colorectal cancer cells by targeting SERCA2.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Differentiation; Proliferation; SERCA2; Tumorigenesis

Mesh:

Substances:

Year:  2014        PMID: 25458791     DOI: 10.1016/j.biopha.2014.10.014

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  Chelerythrine Attenuates the Inflammation of Lipopolysaccharide-Induced Acute Lung Inflammation Through NF-κB Signaling Pathway Mediated by Nrf2.

Authors:  Lu Fan; Ye Fan; Li Liu; Weiwei Tao; Xin Shan; Yu Dong; Lin Li; Sen Zhang; Hanqing Wang
Journal:  Front Pharmacol       Date:  2018-09-26       Impact factor: 5.810

Review 2.  Calcium-ATPases: Gene disorders and dysregulation in cancer.

Authors:  Donna Dang; Rajini Rao
Journal:  Biochim Biophys Acta       Date:  2015-11-30

Review 3.  Darier Disease - A Multi-organ Condition?

Authors:  Etty Bachar-Wikström; Jakob D Wikström
Journal:  Acta Derm Venereol       Date:  2021-04-15       Impact factor: 3.875

4.  Myricetin induces apoptosis via endoplasmic reticulum stress and DNA double-strand breaks in human ovarian cancer cells.

Authors:  Ye Xu; Qi Xie; Shaohua Wu; Dan Yi; Yang Yu; Shibing Liu; Songyan Li; Zhixin Li
Journal:  Mol Med Rep       Date:  2016-01-12       Impact factor: 2.952

5.  Demethoxycurcumin Is A Potent Inhibitor of P-Type ATPases from Diverse Kingdoms of Life.

Authors:  Trong Tuan Dao; Pankaj Sehgal; Truong Thanh Tung; Jesper Vuust Møller; John Nielsen; Michael Palmgren; Søren Brøgger Christensen; Anja Thoe Fuglsang
Journal:  PLoS One       Date:  2016-09-19       Impact factor: 3.240

6.  Identification of Molecular Targets for Predicting Colon Adenocarcinoma.

Authors:  Yansheng Wang; Jun Zhang; Li Li; Xin Xu; Yong Zhang; Zhaowei Teng; Feihu Wu
Journal:  Med Sci Monit       Date:  2016-02-12

7.  Pekinenin E Inhibits the Growth of Hepatocellular Carcinoma by Promoting Endoplasmic Reticulum Stress Mediated Cell Death.

Authors:  Lu Fan; Qingling Xiao; Yanyan Chen; Gang Chen; Jinao Duan; Weiwei Tao
Journal:  Front Pharmacol       Date:  2017-06-29       Impact factor: 5.810

8.  The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.

Authors:  Amelia A Peters; Michael J G Milevskiy; Wei C Lee; Merril C Curry; Chanel E Smart; Jodi M Saunus; Lynne Reid; Leonard da Silva; Daneth L Marcial; Eloise Dray; Melissa A Brown; Sunil R Lakhani; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

9.  Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers.

Authors:  Henry Sung-Ching Wong; Wei-Chiao Chang
Journal:  Oncotarget       Date:  2015-12-08

10.  Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer.

Authors:  Baofang Yang; Minxia Zhang; Jian Gao; Jiahuang Li; Lu Fan; Gang Xiang; Xingqi Wang; Xiaoning Wang; Xuefeng Wu; Yang Sun; Xudong Wu; Guang Liang; Yan Shen; Qiang Xu
Journal:  Oncotarget       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.